{"id":"W4379662222","doi":"10.1200/jco.2023.41.17_suppl.lba4501","title":"Pembrolizumab plus axitinib versus sunitinib as first-line therapy for advanced clear cell renal cell carcinoma: 5-year analysis of KEYNOTE-426.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Renal cell carcinoma; Temsirolimus; Population; Pembrolizumab; Internal medicine; Sunitinib; Interim analysis; Discontinuation; Oncology; Urology; Clinical trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00879295,0.001321867,0.002355142,0.0007862553,0.0003863158,0.001563019,0.00135265,0.001637125,0.003875306],"category_scores_gemma":[0.002751594,0.0006643502,0.005999616,0.0006896164,0.0006562096,0.001571794,0.0007202306,0.003468378,0.0007798813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001825244,"about_ca_system_score_gemma":0.001500073,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001590593,"about_ca_topic_score_gemma":0.003020777,"domain_scores_codex":[0.9975513,0.001298193,0.0001355814,0.000345653,0.0002713694,0.0003979654],"domain_scores_gemma":[0.9973868,0.0005861268,0.0009142349,0.0002534964,0.000128025,0.0007313362],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9260257,0.00966949,0.0184125,0.0006797019,0.008978614,0.00008476005,0.00009228042,0.002870316,0.003546511,0.0001579751,0.001836067,0.02764598],"study_design_scores_gemma":[0.310783,0.4914377,0.1649335,0.0001716399,0.01599912,0.0003549267,0.000157593,0.009880635,0.002397544,0.0004219878,0.00336565,0.0000968742],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886178,0.005663612,0.0008709569,0.0003564327,0.0001477896,0.0007872185,0.00219677,0.00007012916,0.001289341],"genre_scores_gemma":[0.9937837,0.001208927,0.000533528,0.0004534112,0.0001568924,0.0003806834,0.002290616,0.00001522337,0.001176974],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00879295,"threshold_uncertainty_score":0.04650211,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1601011100595345,"score_gpt":0.4468035488967355,"score_spread":0.286702438837201,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}